The medical landscape is seeing a shift with the introduction of GLP-1 transdermal systems . These cutting-edge formulations offer a potential alternative to delivering glucagon-like peptide-1 drugs for https://jesserefq936834.timeblog.net/76821995/glp-1-patches-a-new-way-to-control-diabetes